FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

OncoCalendar

Loading Events

« All Events

  • This event has passed.

The Breast Cancer Symposium 2025

Apr 12 • 8:00 AM - 5:00 PM
Breast Cancer

The Breast Cancer Symposium 2025 will be held on April 12,2025 at Detroit, USA.

The Breast Cancer Symposium 2025, presented by the Barbara Ann Karmanos Cancer Institute and Wayne State University, is designed for healthcare professionals in hematology and oncology, including physicians, surgeons, fellows, residents, pathologists etc.

This annual conference will cover the latest advancements in breast cancer treatment, including updates on HER2+ Breast Cancer, Breast Reconstruction, and an Overview of Anthracycline Use in Breast Cancer. Attendees will gain insights into the multimodal care of breast cancer patients and the evolving strategies in treating these cancers.

The symposium will focus on integrating diagnostic and therapeutic strategies in the treatment of breast cancer, particularly through the use of both cytotoxic and biologic agents. Participants will also have the opportunity to explore the latest research findings and how these developments can impact future decisions in the diagnosis and treatment of breast cancer. This conference will provide a comprehensive learning experience for healthcare professionals, keeping them up-to-date with the most recent and relevant information in the field.

Registration is open for the event until April 10, 2025.

Venue

Detroit, Marriott
200 W. Big Beaver Road Troy 48084 United States + Google Map
View Venue Website